Patterns and predictors of depression treatment among adults with chronic kidney disease and depression in ambulatory care settings in the United States
AffiliationUniv Arizona, Coll Pharm, Dept Pharm Practice & Sci
MetadataShow full item record
CitationVadiei, N. & Bhattacharjee, S. Int Urol Nephrol (2019) 51: 303. https://doi.org/10.1007/s11255-018-2034-3
Rights© Springer Nature B.V. 2018
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at firstname.lastname@example.org.
AbstractOne in five adults with chronic kidney disease (CKD) in the United States (US) suffers from depression. Comorbid depression in adults with CKD is associated with higher morbidity and mortality. This study used US national survey data to examine patterns and predictors of depression treatment among adults with non-dialysis-dependent CKD in the US. A retrospective, cross-sectional study was conducted using 2014-2015 National Ambulatory Medical Care Survey (NAMCS) data. The final study sample consisted of visits by 9.02 million adults (unweighted n = 262; age ≥ 18 years) with CKD and depression in the US. Depression treatment was defined as antidepressant use with or without psychotherapy. To identify predictors of depression treatment, multivariable logistic regression analysis was conducted adjusting for predisposing, enabling, and need factors. Approximately half of adults with CKD and depression received depression treatment. Primary care was the main setting of treatment, and the most commonly prescribed antidepressant class was selective serotonin reuptake inhibitors. Adults being seen for treatment of a chronic problem were 3.2 times more likely to receive depression treatment (OR 3.20; 95% CI 1.38-7.21). In addition, there was a 9% higher likelihood of receiving depression treatment for each unit increase in total number of medications (OR 1.09; 95% CI 1.01-1.19). Finally, adults receiving care in the South were 63% less likely to receive depression treatment (OR 0.37; 95% CI 0.15-0.89). Depression treatment was recorded in approximately half of US ambulatory care visits involving adults with CKD and depression from 2014 to 2015. Further research is warranted to determine how to appropriately manage treatment of depression in adults with CKD.
Note12 month embargo; published online: 4 December 2018
VersionFinal accepted manuscript
- Patterns and Predictors of Depression Treatment among Stroke Survivors with Depression in Ambulatory Settings in the United States.
- Authors: Bhattacharjee S, Axon DR, Goldstone L, Lee JK
- Issue date: 2018 Mar
- When depression is diagnosed, older adults are as likely as younger adults to be prescribed pharmacotherapy and psychotherapy.
- Authors: Choi NG, DiNitto DM, Marti CN, Kunik ME
- Issue date: 2016 Nov - Dec
- Patterns and Predictors of Depression Treatment among Older Adults with Parkinson's Disease and Depression in Ambulatory Care Settings in the United States.
- Authors: Bhattacharjee S, Vadiei N, Goldstone L, Alrabiah Z, Sherman SJ
- Issue date: 2018
- Prevalence, patterns and predictors of depression treatment among community-dwelling older adults with stroke in the United States: a cross sectional study.
- Authors: Bhattacharjee S, Al Yami M, Kurdi S, Axon DR
- Issue date: 2018 May 16
- Undertreatment of anemia in patients with chronic kidney disease in the United States: analysis of national outpatient survey data.
- Authors: Rasu RS, Manley HJ, Crawford T, Balkrishnan R
- Issue date: 2007 Jul